Genetic basis of clinical catecholamine disorders

Annals of the New York Academy of Sciences

Volumn 971, Issue , 2002, Pages 506-514

  Garland, Emily M ^a   Hahn, Maureen K ^a   Ketch, Terry P ^a   Keller, Nancy R ^a   Kim, Chun Hyung ^b   Kim, Kwang Soo ^b   Biaggioni, Italo ^a,c   Shannon, John R ^a,c   Blakely, Randy D ^a   Robertson, David ^a,c,d  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Autonomic disorders; Autonomic nervous system diseases; Blood pressure; Catecholamines; Deficiency; Dopamine; Dopamine hydroxylase; Dysautonomia; Genetic; Heart rate; Norepinephrine; Norepinephrine transporter; Posture

Indexed keywords

DOPAMINE BETA MONOOXYGENASE;

AUTONOMIC NEUROPATHY; BLOOD PRESSURE REGULATION; BRAIN PERFUSION; CATECHOLAMINE RELEASE; CONFERENCE PAPER; DYSAUTONOMIA; ENZYME DEFICIENCY; GENETIC ANALYSIS; HEART RATE VARIABILITY; HUMAN; MEDIATOR RELEASE; NORADRENALIN RELEASE; PROTEIN DOMAIN; SYNAPTIC TRANSMISSION;

EID: 18644380920     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04515.x     Document Type: Conference Paper

References (23)

1. Esler, M., G. Jennings, G. Lambert, et al. 1990. Overflow of catecholamine neurotransmitters to the circulation: Source, fate, functions. Physiol. Rev. 70: 963-985.
2. Goldstein, D.S., G. Eisenhofer, R. Stull, et al. 1988. Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. J. Clin. Invest. 81: 213-220.
3. Goldstein, D.S., J.E. Brush, G. Eisenhofer, et al. 1988. In vivo measurement of neuronal uptake of norepinephrine in the human heart. Circulation 78: 41-48.
4. Iverson, L. 1971. Role of transmitter uptake mechanisms in synaptic neurotransmission. Br. J. Pharmacol. 41: 571-591.
5. LI, S., C. Tack, L. Fananapazir & D.S. Goldstein. 2000. Myocardial perfusion and sympathetic innervation in patients with hypertropic cardiomyopathy. J. Am. Coll. Cardiol. 35: 1867-1873.
6. Robertson, D., M.R. Goldberg, A.S. Hollister, et al. 1986. Isolated failure of autonomic noradrenergic neurotransmission: Evidence for impaired beta-hydroxylation of dopamine. N. Engl. J. Med. 314: 1494-1497.
7. Man in 'T Veld, A.J., F. Boomsma, P. Moleman & M.A. Schalekamp. 1987. Congenital dopamine-β-hydroxylase deficiency: A novel orthostatic syndrome. Lancet 1: 183-188.
8. Robertson, D., V. Haile, S.E. Perry, et al. 1991. Dopamine beta-hydroxylase deficiency. A genetic disorder of cardiovascular regulation. Hypertension 18: 1-8.
9. Kim, C.-H., C.P. Zabetian, J.F. Cubells, et al. 2001. Mutations in the dopamine β-hydroxylase gene are associated with human norepinephrine deficiency. Am. J. Med. Genet. 108: 140-147.
10. Zabetian, C.P., G.M. Anderson, S.G. Buxbaum, et al. 2001. A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: Evidence for a major functional polymorphism at the DBH locus. Am. J. Hum. Genet. 68: 515-522.
11. Jacob, G. & I. Biaggioni. 1999. Idiopathic orthostatic intolerance and postural tachycardia syndromes. Am. J. Med. Sci. 317: 88-101.
12. Jacob, G., D. Robertson, R. Mosqueda-Garcia, et al. 1997. Hypovolemia in syncope and orthostatic intolerance role of the renin-angiotensin system. Am. J. Med. 103: 128-133.
13. Streeten, D.H., G.H.J. Anderson, R. Richardson & F.D. Thomas. 1988. Abnormal orthostatic changes in blood pressure and heart rate in subjects with intact sympathetic nervous function: Evidence for excessive venous pooling. J. Lab. Clin. Med. 111: 326-335.
14. Schondorf, R. & P.A. Low. 1993. Idiopathic postural orthostatic tachycardia syndrome: An attenuated form of acute pandysautonomia? Neurology 43: 132-137.
15. Vernino, S., P.A. Low, R.D. Fealey, et al. 2000. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N. Engl. J. Med. 343: 847-855.
16. Jacob, G., F. Costa, J.R. Shannon, et al. 2000. The neuropathic postural tachycardia syndrome. N. Engl. J. Med. 343: 1008-1014.
17. Shannon, J.R., N.L. Flattem, J. Jordan, et al. 2000. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N. Engl. J. Med. 342: 541-549.
18. Jacob, G., J.R. Shannon, F. Costa, et al. 1999. Abnormal norepinephrine clearance and adrenergic receptor sensitivity in idiopathic orthostatic intolerance. Circulation 99: 1706-1712.
19. Shannon, J.R., J. Jordan, B.K. Black, et al. 1998. Uncoupling of the baroreflex by NN-cholinergic blockade in dissecting the components of cardiovascular regulation. Hypertension 32: 101-107.
20. Moore, R.Y. 1979. Central catecholamine neuron systems: Anatomy and physiology of the norepinephrine and epinephrine systems. Annu. Rev. Neurosci. 2: 113-168.
21. Loughlin, S.E., S.L. Foote & F.E. Bloom. 1986. Efferent projections of nucleus locus coeruleus: Topographic organization of cells of origin demonstrated by three-dimensional reconstruction. Neuroscience 18: 291-306.
22. Grace, A.A., C.R. Gerfen & G. Aston-Jones. 1998. Catecholamines in the central nervous system. Adv. Pharmacol. 42: 655-670.
23. Derogatis, L.R. 1977. SCL-90-R: Administration, Scoring and Procedures Manual-I for the R(evised) Version. Johns Hopkins University School of Medicine. Baltimore.